img

Post-pandemic Era Global Intravenous Immunoglobulin (IVIg) Market Segment Research Report 2024

Published on: 2024-01-04 | No of Pages : 212 | Industry : Medical Devices & Consumables Research Center

Publisher : XMR | Format : PDF

Post-pandemic Era Global Intravenous Immunoglobulin (IVIg) Market Segment Research Report 2024

Summary

The global economy is expected to expand 5.6% in 2021，global recovery is strong but uneven as many emerging market and developing economies continue to struggle with the COVID-19 pandemic, the world is unlikely to ever reach global herd immunity. However, the recovery in many countries is being held back by a resurgence of COVID-19 cases and lagging vaccination progress, as well as the withdrawal of policy support in some instances.

The annual U.S. economic growth rate slipped to -3.5% in 2020, but grew at a yearly pace of more than 6% in the previous two quarters of 2021. The economy of continental Europe bounced back in the second quarter after having contracted in both the fourth quarter of 2020 and the first quarter of 2021, as the vaccinations accelerated, and governments eased restrictions. Among major economies, the annualized growth rate was 6.1% in Germany, 3.6% in France, 11.2% in Italy, and 11.7% in Spain. The especially rapid growth in Spain and Italy was attributed to a surge in consumer spending, likely the result of an easing of economic restrictions.

Regional Economic ProspectsGrowth in the East Asia and Pacific is projected to accelerate by 7.7% in 2021, Central Asia is forecast to grow by 3.9% this year, economic activity in the Middle East and North Africa is forecast to advance by 2.4%, South Asia is projected to expand by 6.8%.

The global Intravenous Immunoglobulin (IVIg) market size was USD XX billion in 2021. It is likely to progress at a CAGR of XX% during the forecast period of 2022-2027, according to MR Accuracy Reports analysis, The segment in Intravenous Immunoglobulin (IVIg) market is estimated to reach a market value of USD XX billion by 2021 from an initial market value of USD XX billion in 2021. China market value in 2021 is about USD XX billion, and China Intravenous Immunoglobulin (IVIg) production is XX (K Units). US market value in 2021 is about USD XX billion, and US Intravenous Immunoglobulin (IVIg) production is XX (K Units). Europe market value in 2021 is about USD XX billion, and Europe Intravenous Immunoglobulin (IVIg) production is XX (K Units).

Regional Segmentation (Value; Revenue, USD Million, 2017 - 2027) of Intravenous Immunoglobulin (IVIg) Market by MR Accuracy Reports Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Intravenous Immunoglobulin (IVIg) Market?
Baxalta
Grifols
CSL
Octapharma
Kedrion
BPL
LFB
Biotest
Kedrion
Major Type of Intravenous Immunoglobulin (IVIg) Covered in MR Accuracy Reports report
IVIG Liquid
IVIG Powder
Application Segments Covered in MR Accuracy Reports Market
Immunodeficiency
Autoimmune Disease
Acute Infection

For any other requirements, please feel free to contact us and we will provide you customized report.

Table of Content

Table of Contents

Global Intravenous Immunoglobulin (IVIg) Market Segment Research Report 2021
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Intravenous Immunoglobulin (IVIg) Market by Value
2.2.1 Global Intravenous Immunoglobulin (IVIg) Revenue by Type
2.2.2 Global Intravenous Immunoglobulin (IVIg) Market by Value (%)
2.3 Global Intravenous Immunoglobulin (IVIg) Market by Production
2.3.1 Global Intravenous Immunoglobulin (IVIg) Production by Type
2.3.2 Global Intravenous Immunoglobulin (IVIg) Market by Production (%)

3. The Major Driver of Intravenous Immunoglobulin (IVIg) Industry
3.1 Historical & Forecast Global Intravenous Immunoglobulin (IVIg) Demand
3.2 Largest Application for Intravenous Immunoglobulin (IVIg) (2017-2027)
3.3 The Major Downstream Company in China Market 2021

4. Global and Regional Intravenous Immunoglobulin (IVIg) Market
4.1 Regional Market Size in Terms of Production & Demand (2021)
4.2 Regional Market Share in Terms of Revenue (2019-2027)
4.3 Concentration Ratio (CR5& CR10) of Intravenous Immunoglobulin (IVIg) Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Intravenous Immunoglobulin (IVIg) Production, Demand (2017-2027)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
5.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

6. Europe Intravenous Immunoglobulin (IVIg) Production, Demand (2017-2027)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
6.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

7. China Intravenous Immunoglobulin (IVIg) Production, Demand (2017-2027)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
7.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

8. Japan Intravenous Immunoglobulin (IVIg) Production, Demand (2017-2027)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
8.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

9. India Intravenous Immunoglobulin (IVIg) Production, Demand (2017-2027)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
9.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

10. Korea Intravenous Immunoglobulin (IVIg) Production, Demand (2017-2027)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
10.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

11. Southeast Asia Intravenous Immunoglobulin (IVIg) Production, Demand (2017-2027)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2017-2027)
11.5 Current and Estimated Revenue Breakdown by Application (2017-2027)

12. Global Intravenous Immunoglobulin (IVIg) Average Price Trend
12.1 Market Price for Each Type of Intravenous Immunoglobulin (IVIg) in US (2017-2021)
12.2 Market Price for Each Type of Intravenous Immunoglobulin (IVIg) in Europe (2017-2021)
12.3 Market Price for Each Type of Intravenous Immunoglobulin (IVIg) in China (2017-2021)
12.4 Market Price for Each Type of Intravenous Immunoglobulin (IVIg) in Japan (2017-2021)
12.5 Market Price for Each Type of Intravenous Immunoglobulin (IVIg) in India (2017-2021)
12.6 Market Price for Each Type of Intravenous Immunoglobulin (IVIg) in Korea (2017-2021)
12.7 Market Price for Each Type of Intravenous Immunoglobulin (IVIg) in Southeast Asia (2017-2021)

13. Industrial Chain (Impact of COVID-19)
13.1 Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Technology Trends of Intravenous Immunoglobulin (IVIg)

14. Intravenous Immunoglobulin (IVIg) Competitive Landscape
14.1 Baxalta
14.1.1 Baxalta Company Profiles
14.1.2 Baxalta Product Introduction
14.1.3 Baxalta Intravenous Immunoglobulin (IVIg) Sales, Revenue (2017-2021)
14.1.4 Strategic initiatives
14.2 Grifols
14.2.1 Grifols Company Profiles
14.2.2 Grifols Product Introduction
14.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue (2017-2021)
14.2.4 Strategic initiatives
14.3 CSL
14.3.1 CSL Company Profiles
14.3.2 CSL Product Introduction
14.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue (2017-2021)
14.3.4 Strategic initiatives
14.4 Octapharma
14.4.1 Octapharma Company Profiles
14.4.2 Octapharma Product Introduction
14.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue (2017-2021)
14.4.4 Strategic initiatives
14.5 Kedrion
14.5.1 Kedrion Company Profiles
14.5.2 Kedrion Product Introduction
14.5.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue (2017-2021)
14.5.4 Strategic initiatives
14.6 BPL
14.6.1 BPL Company Profiles
14.6.2 BPL Product Introduction
14.6.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue (2017-2021)
14.6.4 Strategic initiatives
14.7 LFB
14.7.1 LFB Company Profiles
14.7.2 LFB Product Introduction
14.7.3 LFB Intravenous Immunoglobulin (IVIg) Sales, Revenue (2017-2021)
14.7.4 Strategic initiatives
14.8 Biotest
14.8.1 Biotest Company Profiles
14.8.2 Biotest Product Introduction
14.8.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue (2017-2021)
14.8.4 Strategic initiatives
14.9 Kedrion
14.9.1 Kedrion Company Profiles
14.9.2 Kedrion Product Introduction
14.9.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue (2017-2021)
14.9.4 Strategic initiatives
15. Conclusion


List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Intravenous Immunoglobulin (IVIg) Industry (Volume)
Figure 2. Intravenous Immunoglobulin (IVIg) Production & Demand by Regions in 2021
Figure 3. Regional Market Share in Terms of Revenue (2021&2027)
Figure 4. The Top 10 and 5 Players Market Share by Intravenous Immunoglobulin (IVIg) Revenue in 2021
Figure 5. US Intravenous Immunoglobulin (IVIg) Production, Demand (2017-2027)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Intravenous Immunoglobulin (IVIg) Production, Demand (2017-2027)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Intravenous Immunoglobulin (IVIg) Production, Demand (2017-2027)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Intravenous Immunoglobulin (IVIg) Production, Demand (2017-2027)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Intravenous Immunoglobulin (IVIg) Production, Demand (2017-2027)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Intravenous Immunoglobulin (IVIg) Production, Demand (2017-2027)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Intravenous Immunoglobulin (IVIg) Production, Demand (2017-2027)
Figure 43. Current and Estimated Production Breakdown by Type (2017-2027)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Intravenous Immunoglobulin (IVIg) Revenue, by Type (Million USD) (2017-2027)
Table 4. Intravenous Immunoglobulin (IVIg) Production, by Type (K Unit) (2017-2027)
Table 5. Intravenous Immunoglobulin (IVIg) Demand (K Unit) by Application (2017-2027)
Table 6. Intravenous Immunoglobulin (IVIg) Demand (Million USD) by Application (2017-2027)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2021)
Table 9. Regional Market Share in Terms of Revenue (2021&2027)
Table 10. Ranking of Global Top Intravenous Immunoglobulin (IVIg) Companies by Revenue, Concentration Ratio in 2021
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Intravenous Immunoglobulin (IVIg) Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 13. Current and Estimated Production Breakdown by Type (2017-2027)
Table 14. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 15. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Intravenous Immunoglobulin (IVIg) Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 19. Current and Estimated Production Breakdown by Type (2017-2027)
Table 20. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 21. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Intravenous Immunoglobulin (IVIg) Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Intravenous Immunoglobulin (IVIg) Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 30. Current and Estimated Production Breakdown by Type (2017-2027)
Table 31. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 32. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Intravenous Immunoglobulin (IVIg) Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 36. Current and Estimated Production Breakdown by Type (2017-2027)
Table 37. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 38. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Intravenous Immunoglobulin (IVIg) Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 42. Current and Estimated Production Breakdown by Type (2017-2027)
Table 43. Current and Estimated Demand Breakdown by Type (2017-2027)
Table 44. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Intravenous Immunoglobulin (IVIg) Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2017-2027)
Table 48. Table Current and Estimated Demand Breakdown by Type (2017-2027)
Table 49. Current and Estimated Demand Breakdown by Application (2017-2027)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Intravenous Immunoglobulin (IVIg) in US (2017-2021)
Table 53. Market Price (USD/Unit) for Each Type of Intravenous Immunoglobulin (IVIg) in Europe (2017-2021)
Table 54. Market Price (USD/Unit) for Each Type of Intravenous Immunoglobulin (IVIg) in China (2017-2021)
Table 55. Market Price (USD/Unit) for Each Type of Intravenous Immunoglobulin (IVIg) in Japan (2017-2021)
Table 56. Market Price (USD/Unit) for Each Type of Intravenous Immunoglobulin (IVIg) in India (2017-2021)
Table 57. Market Price (USD/Unit) for Each Type of Intravenous Immunoglobulin (IVIg) in Korea (2017-2021)
Table 58. Market Price (USD/Unit) for Each Type of Intravenous Immunoglobulin (IVIg) in Southeast Asia (2017-2021)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Baxalta Profiles
Table 61. Baxalta Intravenous Immunoglobulin (IVIg) Product Introduction
Table 62. Baxalta Intravenous Immunoglobulin (IVIg) Sales (Unit), Revenue (Million USD) (2017-2021)
Table 63. Baxalta Strategic initiatives
Table 64. Grifols Profiles
Table 65. Grifols Intravenous Immunoglobulin (IVIg) Product Introduction
Table 66. Grifols Intravenous Immunoglobulin (IVIg) Sales (Unit), Revenue (Million USD) (2017-2021)
Table 67. Grifols Strategic initiatives
Table 68. CSL Profiles
Table 69. CSL Intravenous Immunoglobulin (IVIg) Product Introduction
Table 70. CSL Intravenous Immunoglobulin (IVIg) Sales (Unit), Revenue (Million USD) (2017-2021)
Table 71. CSL Strategic initiatives
Table 72. Octapharma Profiles
Table 73. Octapharma Intravenous Immunoglobulin (IVIg) Product Introduction
Table 74. Octapharma Intravenous Immunoglobulin (IVIg) Sales (Unit), Revenue (Million USD) (2017-2021)
Table 75. Octapharma Strategic initiatives
Table 76. Kedrion Profiles
Table 77. Kedrion Intravenous Immunoglobulin (IVIg) Product Introduction
Table 78. Kedrion Intravenous Immunoglobulin (IVIg) Sales (Unit), Revenue (Million USD) (2017-2021)
Table 79. Kedrion Strategic initiatives
Table 80. BPL Profiles
Table 81. BPL Intravenous Immunoglobulin (IVIg) Product Introduction
Table 82. BPL Intravenous Immunoglobulin (IVIg) Sales (Unit), Revenue (Million USD) (2017-2021)
Table 83. BPL Strategic initiatives
Table 84. LFB Profiles
Table 85. LFB Intravenous Immunoglobulin (IVIg) Product Introduction
Table 86. LFB Intravenous Immunoglobulin (IVIg) Sales (Unit), Revenue (Million USD) (2017-2021)
Table 87. LFB Strategic initiatives
Table 88. Biotest Profiles
Table 89. Biotest Intravenous Immunoglobulin (IVIg) Product Introduction
Table 90. Biotest Intravenous Immunoglobulin (IVIg) Sales (Unit), Revenue (Million USD) (2017-2021)
Table 91. Biotest Strategic initiatives
Table 92. Kedrion Profiles
Table 93. Kedrion Intravenous Immunoglobulin (IVIg) Product Introduction
Table 94. Kedrion Intravenous Immunoglobulin (IVIg) Sales (Unit), Revenue (Million USD) (2017-2021)

Select User License

$2700 Single Licence
$4500 Enterprise Licence
$5900 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries